[go: up one dir, main page]

WO2024065760A1 - Composition pour le soin des matières kératiniques - Google Patents

Composition pour le soin des matières kératiniques Download PDF

Info

Publication number
WO2024065760A1
WO2024065760A1 PCT/CN2022/123481 CN2022123481W WO2024065760A1 WO 2024065760 A1 WO2024065760 A1 WO 2024065760A1 CN 2022123481 W CN2022123481 W CN 2022123481W WO 2024065760 A1 WO2024065760 A1 WO 2024065760A1
Authority
WO
WIPO (PCT)
Prior art keywords
oil
composition
hydroxypropane
propan
composition according
Prior art date
Application number
PCT/CN2022/123481
Other languages
English (en)
Inventor
Xinxin Chen
Shanshan ZANG
Yao GU
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Priority to CN202280099630.1A priority Critical patent/CN119836285A/zh
Priority to PCT/CN2022/123481 priority patent/WO2024065760A1/fr
Priority to FR2211968A priority patent/FR3140267B1/fr
Publication of WO2024065760A1 publication Critical patent/WO2024065760A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A61K8/988—Honey; Royal jelly, Propolis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Definitions

  • the present invention relates to a cosmetic composition.
  • the present invention relates to a composition for caring for keratin materials.
  • the present invention also relates to a non-therapeutic method for caring for keratin materials.
  • the skin is the protective barrier for the human body. It protects the interior of the body from physical injury (such as trauma) and biological injury (such as bacteria, viruses or fungi) .
  • hydroxypropyl tetrahydropyrantriol is a well-known ingredient which can immediately improve skin quality, result in good moisturizing and rejuvenate skin after long-term usage.
  • US20210015719A1 discloses an emulsified gel composition having an emulsified gel system having an emulsifier and a hyaluronic acid delivery component comprising a combination of a hyaluronic acid, a hyaluronidase inhibitor and hydroxypropyl tetrahydropyrantriol, which provdies an improved barrier function.
  • cosmeitc products which can deliver a soft and smooth skin sensory as well as refine looking.
  • compositions able to deliver a soft and smooth skin sensory as well as refine looking are now discovered.
  • the present invention provides a composition for caring for keratin materials, comprising:
  • R represents a saturated C 1 to C 10 , in particular C 1 to C 4 , alkyl radical which can optionally be substituted by at least one radical selected from OH, COOH or COOR” 2 , with R” 2 being a saturated C 1 -C 4 alkyl radical,
  • - S represents a monosaccharide or a polysaccharide comprising up to 20 sugar units, in particular up to 6 sugar units, in pyranose and/or furanose form and of the L and/or D series, it being possible for the said monosaccharide or polysaccharide to be substituted by a hydroxyl group which is necessarily free and optionally one or more optionally protected amine functional group (s) , and
  • -X represents a radical selected from the–CO-, -CH (OH) -, -CH (NH 2 ) -, -CH (NHCH 2 CH 2 CH 2 OH) -, -CH (NHPh) -and–CH (CH 3 ) -groups and in particular a–CO-, -CH (OH) -or–CH (NH 2 ) -radical and more particularly a–CH (OH) -radical,
  • the S-CH 2 -X bond represents a bond of C-anomeric nature, which can be ⁇ or ⁇ ,
  • composition of the present invention can deliver a soft and smooth skin sensory as well as refine looking.
  • the present invention provides a non-therapeutic method for caring for keratin materials, comprising applying the composition according to the first aspect of the present invention to the keratin materials.
  • keratin materials is intended to cover human skin, mucous membranes such as the lips. Facial skin is most particularly considered according to the present invention.
  • the present invention provides a composition for caring for keratin materials, comprising:
  • composition of the present invention comprises at least one C-glycoside selected from compounds of formula (I) :
  • R represents a saturated C 1 to C 10 , in particular C 1 to C 4 , alkyl radical which can optionally be substituted by at least one radical selected from OH, COOH or COOR” 2 , with R” 2 being a saturated C 1 -C 4 alkyl radical,
  • - S represents a monosaccharide or a polysaccharide comprising up to 20 sugar units, in particular up to 6 sugar units, in pyranose and/or furanose form and of the L and/or D series, it being possible for the said monosaccharide or polysaccharide to be substituted by a hydroxyl group which is necessarily free and optionally one or more optionally protected amine functional group (s) , and
  • - X represents a radical selected from the–CO-, -CH (OH) -, -CH (NH 2 ) -, -CH (NHCH 2 CH 2 CH 2 OH) -, -CH (NHPh) -and–CH (CH 3 ) -groups and in particular a–CO-, -CH (OH) -or–CH (NH 2 ) -radical and more particularly a–CH (OH) -radical,
  • the S-CH 2 -X bond represents a bond of C-anomeric nature, which can be ⁇ or ⁇ , and also their physiologically acceptable salts, their solvates, such as the hydrates, and their optical and geometrical isomers.
  • the C-glycoside of use for the implementation of the invention are in particular those for which R denotes a saturated linear C 1 to C 6 , in particular C 1 to C 4 , preferentially C 1 to C 2 , alkyl radical and more preferably a methyl radical.
  • a monosaccharide of the invention can be selected from D-glucose, D-galactose, D-mannose, D-xylose, D-lyxose or L-fucose, L-arabinose, L-rhamnose, D-glucuronic acid, D-galacturonic acid, D-iduronic acid, N-acetyl-D-glucosamine or N-acetyl-D-galactosamine and advantageously denotes D-glucose, D-xylose, N-acetyl-D-glucosamine or L-fucose and in particular D-xylose.
  • apolysaccharide of the invention comprising up to 6 sugar units can be selected from D-maltose, D-lactose, D-cellobiose, D-maltotriose, adisaccharide combining a uronic acid selected from D-iduronic acid or D-glucuronic acid with a hexosamine selected from D-galactosamine, D-glucosamine, N-acetyl-D-galactosamine or N-acetyl-D-glucosamine, an oligosaccharide comprising at least one xylose which can advantageously be selected from xylobiose, methyl- ⁇ -xylobioside, xylotriose, xylotetraose, xylopentaose and xylohexaose and in particular xylobiose, which is composed of two xylose molecules linked via a 1-4 bond.
  • S can represent a monosaccharide selected from D-glucose, D-xylose, L-fucose, D-galactose or D-maltose and in particular D-xylose.
  • - R denotes an unsubstituted linear C 1 -C 4 , in particular C 1 -C 2 , alkyl radical, especially a methyl radical;
  • - S represents a monosaccharide as described above and selected in particular from D-glucose, D-xylose, N-acetyl-D-glucosamine or L-fucose, and in particular D-xylose;
  • - X represents a group selected from-CO-, -CH (OH) -or-CH (NH 2 ) -and preferably a-CH (OH) -group.
  • the acceptable salts of the compounds described in the present invention comprise conventional non-toxic salts of the said compounds, such as those formed from organic or inorganic acids. Mention may be made, by way of example, of the salts of inorganic acids, such as sulfuric acid, hydrochloric acid. Mention may also be made of the salts of organic acids, which can comprise one or more carboxylic, sulfonic or phosphonic acid groups. Mention may in particular be made of propionic acid, acetic acid, terephthalic acid, citric acid and tartaric acid.
  • neutralization of the acid group (s) can be carried out with an inorganic base, such as LiOH, NaOH, KOH, Ca (OH) 2 , NH 4 OH, Mg (OH) 2 or Zn (OH) 2 , or with an organic base, such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine.
  • an inorganic base such as LiOH, NaOH, KOH, Ca (OH) 2 , NH 4 OH, Mg (OH) 2 or Zn (OH) 2
  • organic base such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine.
  • This primary, secondary or tertiary alkylamine can comprise one or more nitrogen and/or oxygen atoms and can thus comprise, for example, one or more alcohol functional groups; mention may in particular be made of 2-amino-2-methylpropanol, triethanolamine, 2- (dimethylamino) propanol or 2-amino-2- (hydroxymethyl) -1, 3-propanediol. Mention may also be made of lysine or 3- (dimethylamino) propylamine.
  • solvates which are acceptable for the compounds described in the present invention comprise conventional solvates, such as those formed during the final stage of preparation of the said compounds due to the presence of solvents. Mention may be made, by way of example, of the solvates due to the presence of water or of linear or branched alcohols, such as ethanol or isopropanol.
  • a C-glycoside corresponding to the formula (I) can be used alone or as a mixture with other C-glycoside and in any proportion.
  • a C-glycoside which is suitable for the invention can in particular be obtained by the synthetic method described in the document WO 02/051828.
  • C- ⁇ -D-xylopyranoside-2-hydroxypropane or C- ⁇ -D-xylopyranoside-2-hydroxypropane and better still C- ⁇ -D-xylopyranoside-2-hydroxypropane can advantageously be used for the preparation of a composition according to the invention.
  • the C-glycoside can be C- ⁇ -D-xylopyranoside-2-hydroxypropane (or hydroxypropyl tetrahydropyrantriol) provided in the form of a solution containing 70%by weight of active material in water and propylene glycol.
  • the C-glycoside is present in the composition of the present invention in an amount ranging from 0.01 wt. %to 40 wt. %, preferably from 0.05 wt. %to 25 wt. %, and more preferably from 0.1 wt. %to 15 wt. %, relative to the total weight of the composition.
  • the composition of the present invention comprises a honey extract.
  • the honey extract is derived comprises honey of a floral origin substantially from the genus Leptospermum.
  • the honey from which the extract is derived comprises honey of a floral origin substantially from: Leptospermum scoparium, Leptospermum polygalifolium, Leptospermum submur, and/or combinations thereof.
  • the honey from which the extract is derived comprises honey of a floral origin substantially from Leptospermum scoparium (also referred to as Manuka) .
  • the honey extract is derived from a floral origin substantially from the genus Leptospermum.
  • the honey extract is derived from a floral origin substantially from: Leptospermum scoparium, Leptospermum polygalifolium, Leptospermum submur, and combinations thereof.
  • the honey from which the extract is derived is of a floral origin substantially from Leptospermum scoparium.
  • HONEY EXTRACT sold under the name MANUKA HONEY EXTRACT GL (WATSON) by the company SOUTHERN CROSS BOTANICALS, which is Manuka honey extract.
  • the honey extract is present in the composition of the present invention in an amount ranging from 0.01 wt. %to 25 wt. %, preferably from 0.05 wt. %to 10 wt. %, and more preferably from 0.1 wt. %to 5 wt. %, relative to the total weight of the composition.
  • the composition of the present invention comprises an essential oil combination of lavender oil, geranium oil and bitter orange flower oil.
  • Lavender oil is an essential oil derived from the lavender plant.
  • Lavender oil can be extracted from Lavandula angustifolia (English lavender or common lavender) , Lavandula burnamii, Lavandula dentata (French lavender) , Lavandula dhofarensis, Lavandula latifolia (Portuguese lavender) , Lavandula officinalis, Lavandula stoechas (Spanish lavender) , lavandin, other garden varieties of lavender, or combinations thereof.
  • the oil is made by distilling the lavender buds, capturing the steam, and condensing the steam into a liquid.
  • Lavender oil can benefit the skin in numerous ways.
  • lavender oil The main chemical components of lavender oil are ⁇ -pinene, limonene, 1, 8-cineole, cis-ocimene, trans-ocimene, 3-octanone, camphor, linalool, linalyl acetate, caryophyllene, terpinen-4-ol and lavendulyl acetate.
  • the compounds responsible for the pleasant scent of lavender are linalyl acetate and linalool.
  • Linalool (3, 7-Dimethyl-1, 6-octadien-3-ol) refers to two enantiomers of a naturally occurring terpene alcohol found in many flowers and spice plants and has a sedative effect. Linalool is shown below.
  • Linalool belongs to the class of organic compounds known as acyclic monoterpenoids. Relevant to its mechanism of action, linalool behaves as a competitive antagonist of glutamate and as a non-competitive antagonist of NMDA receptors in brain cortical membranes. Linalool is believed to be responsible for lavender oil's therapeutic effect in alleviating skin burns without scarring (Gattefosse, “Aromatherapy, ” Penguin Random House, 1993) .
  • the lavender oil useful for the composition of the present invention is obtained from the leaf, root, flowers, bud or plant of Lavandula angustifolia, Lavandula burnamii, Lavandula dentate, Lavandula dhofarensis, Lavandula latifolia, Lavandula officinalis, Lavandula stoechas, or combinations thereof.
  • the lavender oil used is Lavandula angustifolia oil.
  • the lavender oil is present in the composition of the present invention in an amount ranging from 0.001 wt. %to 5%, preferably from 0.001 wt. %to 1 wt. %, and more preferably from 0.001 wt. %to 0.1 wt. %, relative to the total weight of the composition.
  • Geranium is a herbaceous plant belonging to the Geraniaceae family.
  • Geranium oil is mainly available in two varieties, namely Pelargonium roseum asperum CV Bourbon and Pelargonium roseum asperum CV North Africa (Egypt) .
  • Geranium oil consists essentially of a combination of three monoterpenols, namely citronellol (18%to 32%) , geraniol (8%to 20%) and linalool (1.8%to 11%) , and also corresponding terpenic esters.
  • Geranium oil is prepared by conventional distillation by steam entrainment using geranium leaves and stems.
  • Steam entrainment corresponds to vaporization, in the presence of steam, of a sparingly water-miscible substance.
  • the raw material is placed in contact with boiling water or steam in a stillpot.
  • the steam entrains the essential oil vapor, which is condensed in the condenser and recovered as a liquid phase in a Florentine vase (or essence jar) , where the essential oil is separated from the water by settling.
  • the aqueous distillate that remains after the steam entrainment, once the separation of the essential oil has been performed, is known as the “aromatic water” or “hydrolate” or “distilled floral water” .
  • An example of geranium oil according to the present invention that may be mentioned is the product sold by Elixens under the name Pelargonium Graveolens Flower
  • the geranium oil is derived from pelargonium graveolens, pelargonium odorantissimum plant species, or both.
  • the geranium oil is pelargonium graveolens flower oil.
  • the geranium oil is present in the composition of the present invention in an amount ranging from 0.001 wt. %to 5%, preferably from 0.001 wt. %to 1 wt. %, and more preferably from 0.001 wt. %to 0.1 wt. %, relative to the total weight of the composition.
  • bitter orange flower oil (or neroli) is an essential product, largely used in perfumery. Neroli is obtained by hydrodistillation or steam distillation, from the flowers of bitter orange (Citrus aurantium L. ) .
  • Bitter orange is also known as Citrus aurantium amara, sour orange, Seville orange, or marmalade orange.
  • the bitter orange flower oil is present in the composition of the present invention in an amount ranging from 0.001 wt. %to 5 wt. %, preferably from 0.001 wt. %to 1 wt. %, more preferably from 0.001 wt. %to 0.1 wt. %, relative to the total weight of the composition.
  • the inventors have found that with an essential oil combination of lavender oil, geranium oil, and bitter orange flower oil, the composition obtained can deliver a smoother and soft skin feeling and a more refine looking.
  • composition of the present invention may comprise an aqueous phase.
  • Said aqueous phase comprises water.
  • the aqueous phase comprises an organic solvent miscible with water (at room temperature 25°C) selected from ethanol, glycols and polyols having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and preferentially having from 2 to 6 carbon atoms, such as glycerin, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, diethylene glycol; and mixtures thereof, so as to provide a hydration effect.
  • an organic solvent miscible with water selected from ethanol, glycols and polyols having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and preferentially having from 2 to 6 carbon atoms, such as glycerin, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol, dipropylene glycol, diethylene glycol; and
  • the organic solvent miscible with water selected from glycols and polyols is present in the composition in an amount ranging from 0.5 wt. %to 30 wt. %, preferably from 1 wt. %to 20 wt. %, relative to the total weight of the composition.
  • the aqueous phase of the composition of the present invention comprises water and glycerin.
  • aqueous phase is present in the composition of the present invention in an amount ranging from 50 wt. %to 95 wt. %, preferably from 70 wt. %to 95 wt. %, relative to the total weight of the composition.
  • composition of the present invention comprises an oily phase.
  • Said oily phase comprises an additional oil in addition to the essential oils mentioned above.
  • the additional oil can be volatile or non-volatile.
  • oil means a water-immiscible non-aqueous compound that is liquid at room temperature (25°C) and at atmospheric pressure (760 mmHg) .
  • non-volatile oil means an oil that may remain on keratin materials at room temperature and atmospheric pressure for at least several hours and that especially has a vapour pressure of less than 10 -3 mmHg (0.13 Pa) .
  • a non-volatile oil may also be defined as having an evaporation rate such that, under the conditions defined previously, the amount evaporated after 30 minutes is less than 0.07 mg/cm 2 .
  • the additional oils may be of plant, mineral or synthetic origin.
  • Said additional oil can be selected from hydrocarbonated, silicone or fluorinated oils.
  • hydrocarbon-based oil means an oil formed essentially from, or even constituted by, carbon and hydrogen atoms, and optionally O and N atoms, and free of Si and F heteroatoms. Such oil can contain alcohol, ester, ether, carboxylic acid, amine and/or amide groups.
  • silicon oil means an oil containing at least one silicon atom, especially containing Si-O groups.
  • fluorinated oil means an oil containing at least one fluorine atom.
  • the additional oil is selected from hydrocarbon-based oils, and silicone oils, such as dimethicone.
  • the oily phase is present in the composition of the present invention in an amount ranging from 1 wt. %to 20 wt. %, preferably from 2 wt. %to 10 wt. %, relative to the total weight of the composition of the present invention.
  • composition of the present invention may comprise one or more additional cosmetic active ingredient different from C-glycoside, honey extract and essential oils mentioned above.
  • cosmetic active ingredient examples include natural extracts; vitamins such as vitamin A (retinol) , vitamin E (tocopherol) , vitamin C (ascorbic acid) , vitamin B5 (panthenol) , vitamin B3 (niacinamide) , and derivatives of said vitamins (in particular esters) and mixtures thereof; urea; caffeine; salicylic acid and derivatives thereof; alpha-hydroxyacids such as lactic acid or glycolic acid and derivatives thereof; sunscreens; extracts from algae, fungi, plants, yeasts and bacteria; enzymes; moisturing agents such as hydroxyethyl urea, and mixtures thereof.
  • vitamins such as vitamin A (retinol) , vitamin E (tocopherol) , vitamin C (ascorbic acid) , vitamin B5 (panthenol) , vitamin B3 (niacinamide) , and derivatives of said vitamins (in particular esters) and mixtures thereof; urea; caffeine; salicylic acid and derivatives thereof
  • composition of the present invention may also comprise conventional cosmetic adjuvants or additives, for instance, surfactants, fragrances, preserving agents (for example, chlorphenesin, hydroxyacetophenone, and phenoxyethanol) and bactericides, pH regulators (for example citric acid) , thickeners such as xanthan gum, and mixtures thereof.
  • cosmetic adjuvants or additives for instance, surfactants, fragrances, preserving agents (for example, chlorphenesin, hydroxyacetophenone, and phenoxyethanol) and bactericides, pH regulators (for example citric acid) , thickeners such as xanthan gum, and mixtures thereof.
  • the present invention provides a composition for caring for keratin materials comprising, relative to the total weight of the composition:
  • composition of the present invention may be in the form of emulsion, gel, cream, or lotion.
  • composition of the present invention can be used for caring for keratin materials, for example, the face.
  • the present invention provides a non-therapeutic method for caring for keratin materials, comprising applying the composition according to the first aspect of the present invention to the keratin materials.
  • the keratin materials are the skin, especially the face.
  • compositions of invention examples (IE. ) 1-2 and comparative example (CE. ) 1 were prepared according to the amounts given in Table 2. The amount of each component is given in%by weight of the total weight of the composition containing it.
  • composition of invention examples 1-2 are compositions according to the present invention.
  • Composition of comparative example 1 does not comprise lavandula angustifolia (lavender) oil, pelargonium graveolens flower oil, and citrus aurantium amara (bitter orange) flower oil.
  • compositions listed above were prepared as follows, taking the composition of invention example 1 as an example:
  • the viscosity of a composition was measured at 25°C upon preparation using a Rheomat 100 Plus viscometer equipped with a spindle M2 or M3, the measurement being performed after 10 minutes of rotation of the spindle in a composition (after which time stabilization of the viscosity and of the spin speed of the spindle are observed) , at a shear rate of 200 rpm.
  • the stability of a composition will be evaluated as PASS if its appearance, color, and odor do not show visible change, and its viscosity and pH as well as particle sizes of emulsified droplets do not change more than 7%after all of the stability tests mentioned above, otherwise, it will be evaluated as FAILED.
  • compositions of invention examples 1-2 and comparative example 1 were evaluated as follows.
  • the performance level was given based on the following standard on whether (i) skin feels softer, (ii) skin texture is more refine, and (iii) skin feels more smoother.
  • composition of invention examples 1 and 2 performed better on skin softness, refiness, and smoothness, as compared with composition of comparative example 1.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

Composition pour le soin des matières kératiniques comprenant : au moins un C-glycoside; de l'extrait de miel; et une combinaison d'huiles essentielles de lavande, de géranium et de fleur d'oranger amer. Procédé non thérapeutique de soin des matières kératiniques comprenant l'application de ladite composition sur les matières kératiniques.
PCT/CN2022/123481 2022-09-30 2022-09-30 Composition pour le soin des matières kératiniques WO2024065760A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN202280099630.1A CN119836285A (zh) 2022-09-30 2022-09-30 用于护理角蛋白材料的组合物
PCT/CN2022/123481 WO2024065760A1 (fr) 2022-09-30 2022-09-30 Composition pour le soin des matières kératiniques
FR2211968A FR3140267B1 (fr) 2022-09-30 2022-11-17 Composition de soin des matières kératineuses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2022/123481 WO2024065760A1 (fr) 2022-09-30 2022-09-30 Composition pour le soin des matières kératiniques

Publications (1)

Publication Number Publication Date
WO2024065760A1 true WO2024065760A1 (fr) 2024-04-04

Family

ID=90475636

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/123481 WO2024065760A1 (fr) 2022-09-30 2022-09-30 Composition pour le soin des matières kératiniques

Country Status (3)

Country Link
CN (1) CN119836285A (fr)
FR (1) FR3140267B1 (fr)
WO (1) WO2024065760A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080008673A1 (en) * 2006-07-03 2008-01-10 Claudie Willemin Compositions comprising at least one C-glycoside derivative
FR2918545A1 (fr) * 2007-07-12 2009-01-16 Oreal Ensemble pour le conditionnement et l'application d'une composition cosmetique, y compris de soin, sur les matieres keratiniques.
CN101484128A (zh) * 2006-07-03 2009-07-15 欧莱雅公司 包含至少一种c-糖苷衍生物和至少一种透明质酸的组合物及其美容用途
US20210401715A1 (en) * 2020-06-30 2021-12-30 L'oreal Cosmetic composition for improved penetration
WO2022006047A1 (fr) * 2020-06-30 2022-01-06 L'oreal Composition cosmétique pour pénétration améliorée

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818547B1 (fr) 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
WO2015025112A1 (fr) * 2013-08-23 2015-02-26 Mitchell Deborah Composition pour la peau comprenant du venin de reine-abeille
US10660847B2 (en) * 2017-03-17 2020-05-26 Mary Kay Inc. Cosmetic compositions and methods
US20210015719A1 (en) 2017-06-05 2021-01-21 L'oreal Stable emulsified gel composition having a high concentration of active components

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080008673A1 (en) * 2006-07-03 2008-01-10 Claudie Willemin Compositions comprising at least one C-glycoside derivative
CN101484128A (zh) * 2006-07-03 2009-07-15 欧莱雅公司 包含至少一种c-糖苷衍生物和至少一种透明质酸的组合物及其美容用途
FR2918545A1 (fr) * 2007-07-12 2009-01-16 Oreal Ensemble pour le conditionnement et l'application d'une composition cosmetique, y compris de soin, sur les matieres keratiniques.
US20210401715A1 (en) * 2020-06-30 2021-12-30 L'oreal Cosmetic composition for improved penetration
WO2022006047A1 (fr) * 2020-06-30 2022-01-06 L'oreal Composition cosmétique pour pénétration améliorée

Also Published As

Publication number Publication date
FR3140267A1 (fr) 2024-04-05
FR3140267B1 (fr) 2024-10-11
CN119836285A (zh) 2025-04-15

Similar Documents

Publication Publication Date Title
JP3805798B2 (ja) 化粧料
KR101549299B1 (ko) 연꽃 식물 태좌 세포 배양 추출물을 함유한 항노화, 항염, 항산화 화장료 조성물
JPWO2005034894A1 (ja) 育毛剤組成物
WO2019088213A1 (fr) Composition contenant un d-chiro-inositol
KR20150039187A (ko) 모란꽃 식물 태좌 세포 배양 추출물을 함유한 항노화, 항염, 항산화 화장료 조성물
CN110090185A (zh) 一种雪莲花提取物制备面膜的方法
KR101914623B1 (ko) 식물 유래의 오일을 유효성분으로 함유하는 피부 보습용 조성물
KR20220144197A (ko) 혼합식물 정유를 이용한 향수 조성물, 이를 이용하여 제조한 향수 및 이의 제조방법
JP2008150314A (ja) 美白剤
WO2019088211A1 (fr) Composition contenant un d-chiro-inositol
US11779527B2 (en) Useful compositions for the cosmetic treatment of oily skin
WO2024065760A1 (fr) Composition pour le soin des matières kératiniques
CN108186426A (zh) 一种抑菌面膜液、面膜及其制备方法
KR102335683B1 (ko) 해당화 추출물 및 곰보배추 추출물을 유효성분으로 함유하는 여드름 완화용 화장료 조성물
JP3936968B2 (ja) 天然物由来の抗菌剤、抗菌性香料および、それらを含有する化粧品
CN102860942A (zh) 眼部护理复方精油
JP2006052198A (ja) デオドラント剤、デオドラント製剤、および繊維デオドラント処理方法
KR102211409B1 (ko) 열에 의한 피부 손상 방지용 화장료 조성물
WO2023111008A2 (fr) Composition aqueuse parfumée comprenant au moins deux tensioactifs, au moins une substance parfumante et au moins un diol
JP2006257058A (ja) リパーゼ阻害剤及びそれを配合した頭髪用剤及び皮膚外用剤。
JP2017039699A (ja) カスパーゼ−１４発現促進剤
KR100441131B1 (ko) 천연 향유를 함유하는 여드름 화장료 조성물
WO2024065763A1 (fr) Composition pour le soin des matières kératiniques
JP6112498B2 (ja) 防腐剤・界面活性剤フリーの化粧品原料液、化粧品及び化粧品原料液の調製法
KR101726854B1 (ko) 산양삼 추출물을 함유하는 피부 보습용 미스트 조성물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22960373

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE